TREVOSE, Pa.--(BUSINESS WIRE)--Lannett Company, Inc. (the “Company” or “Lannett”) today announced that it and certain of its subsidiaries have successfully emerged from their Chapter 11 cases ...
HENDERSONVILLE, TN / ACCESSWIRE / July 19, 2019 / The Law Offices of Timothy L. Miles, who has been leading the fight to protect shareholder rights for over 18 years, announces that Lannett Company ...
Starting in April, a little-known generic drug company in Philadelphia suddenly raised the price of fluphenazine, a medication used to treat symptoms of certain types of schizophrenia, by 1,650% over ...
Lannett Company has quietly grown revenue and net income at impressive rates over the past five years. Moving forward, industry trends offer significant long-term growth potential for Lannett's ...
These are trying times for Lannett Company shareholders. Over the past 12 months, the generic drugmaker's stock has plunged more than 70%. What will it take for Lannett to bounce back? Here are the ...
PHILADELPHIA, Nov. 27, 2015 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has completed the acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the U.S. specialty ...
Lannett recently received good news from the Food and Drug Administration regarding the development of its biosimilar insulin glargine, a product the company is co-developing with its strategic ...
Levothyroxine's loss has already been factored in many times over. Lannett has too much debt, but it is still just about manageable. I suspect the company's ongoing free cash flow will be at least $50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback